SCHEMBL12656182

SCHEMBL12656182

CC(C)(C)SSCCC(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.57
LMNA P02545 5/20 0.48
KMT2A Q03164 1/20 0.48
HSD17B10 Q99714 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
ALKBH5 Q6P6C2 1/20 0.38
SUCNR1 Q9BXA5 1/20 0.38
EGLN1 Q9GZT9 1/20 0.38
CYP1A2 P05177 1/20 0.38
FOLH1 Q04609 2/20 0.38
FFAR3 O14843 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
SLC15A2 Q16348 1/20 0.36
SLC22A6 Q4U2R8 1/20 0.35
HMGCR P04035 1/20 0.35
CHRM1 P11229 1/20 0.35
TBXA2R P21731 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31457164 0.85 TSHR (0.48) TSHRLMNAKMT2AHSD17B10TDP1
SCHEMBL28351803 0.85 LMNA (0.50) TSHRLMNAKMT2AHSD17B10TDP1
SCHEMBL2128079 0.79 TSHR (0.50) TSHRLMNAKMT2AHSD17B10TDP1
SCHEMBL28682195 0.79 TDP1 (0.38) TSHRLMNATDP1
SCHEMBL16578196 0.79 TSHR (0.36) TSHRLMNAFOLH1HDAC3HDAC1
SCHEMBL8608901 0.77 TSHR (0.52) TSHRLMNAKMT2AHSD17B10TDP1
SCHEMBL6584433 0.77 CYP2D6 (0.55) TSHRHSD17B10TDP1FFAR3HMGCR
SCHEMBL19733437 0.75 ALDH1A1 (0.38) TSHRLMNAFOLH1SLC15A2
SCHEMBL22987326 0.75 CNR1 (0.33) TSHRLMNAKMT2ACYP1A2FOLH1
SCHEMBL95982 0.74 TSHR (1.00) TSHRLMNAKMT2AHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118256591-A Cyclic peptide compound having high membrane permeability and library comprising same 中外制药株式会社 2024-06-28 CN disclosed
CN-110869544-B Cyclic peptide compound having high membrane permeability and library comprising same 中外制药株式会社 2024-03-08 CN disclosed
EP-2813512-B1 PEPTIDE-COMPOUND CYCLIZATION METHOD CHUGAI PHARMACEUTICAL CO LTD (JP) 2021-03-31 EP disclosed
WO-2011062640-A1 COMPOUNDS AS L-CYSTINE CRYSTALLIZATION INHIBITORS AND USES THEREOF NEW YORK UNIVERSITY (US) 2011-05-26 WO disclosed